Cancer-EX
Company

Cancer-EX

Biotechnology Research 6 employees
Employees
6

Cancer-EX Overview

Industry
Biotechnology Research
Employees
6
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Cancer-EX

We are using a Lateral Flow Assay based test, similar to a pregnancy test-strip, to detect the presence of a target biomarker in the saliva. This test will be inexpensive than other imaging tests such as MRI by a factor of 1000 and Blood tests for Pancreatic Cancer by a factor of 90 while being completely non-invasive.

Compare Similar Companies to Cancer-EX